Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rienk Offringa

Showing results (111-120 of 115) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 115 results.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
Journal for Immunotherapy of Cancer|May 23, 2022
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activationAntonio Sorrentino, Ayse Nur Menevse, Tillmann Michels, et al.
Science Translational Medicine|March 18, 2011
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphomaBart Burington, Peng Yue, Xiaoyan Shi, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
Oncoimmunology|February 10, 2022
T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interactionJessica Pinkert, Hans-Henning Boehm, Mark Trautwein, et al.
Pageof 12

Showing results (111-120 of 115) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 115 results.
Carcinogenesis|August 7, 2016
Association of genetic polymorphisms with survival of pancreatic ductal adenocarcinoma patientsCosmeri Rizzato, Daniele Campa, Renata Talar-Wojnarowska, et al.
Journal for Immunotherapy of Cancer|May 23, 2022
Salt-inducible kinase 3 protects tumor cells from cytotoxic T-cell attack by promoting TNF-induced NF-κB activationAntonio Sorrentino, Ayse Nur Menevse, Tillmann Michels, et al.
Science Translational Medicine|March 18, 2011
CD40 pathway activation status predicts response to CD40 therapy in diffuse large B cell lymphomaBart Burington, Peng Yue, Xiaoyan Shi, et al.
Journal for Immunotherapy of Cancer|November 14, 2023
Targeting the aryl hydrocarbon receptor (AhR) with BAY 2416964: a selective small molecule inhibitor for cancer immunotherapyChristina Kober, Julian Roewe, Norbert Schmees, et al.
Oncoimmunology|February 10, 2022
T cell-mediated elimination of cancer cells by blocking CEACAM6-CEACAM1 interactionJessica Pinkert, Hans-Henning Boehm, Mark Trautwein, et al.
Pageof 12